Canine Leptospirosis: Zoonotic Risk, Vaccination, and Diagnostic Approaches

Introduction

Canine leptospirosis is a globally distributed bacterial disease caused by pathogenic spirochetes of the genus Leptospira. The infection is maintained in nature through reservoir hosts, primarily rodents, but also wild and domestic animals, leading to incidental infection in dogs. The disease presents with acute renal and hepatic failure, pulmonary hemorrhage, and coagulopathies, and carries a substantial zoonotic risk due to direct or indirect contact with infected urine. In recent years, emerging serogroups in urban settings, climate-driven shifts in reservoir distribution, and improved molecular detection tools have reshaped the diagnostic and preventive landscape. This article provides a detailed review of the bacteriological, immunological, and clinical aspects of canine leptospirosis with emphasis on zoonotic potential, vaccination strategies, and modern diagnostic approaches.

Etiology and Host Interactions

Leptospira are Gram-negative, obligate aerobic spirochetes with periplasmic flagella that enable motility in viscous environments. Pathogenic species such as Leptospira interrogans and Leptospira kirschneri are classified into serogroups based on lipopolysaccharide (LPS) antigenic structure. Dogs are incidental hosts, and the bacteria enter through mucous membranes or abraded skin, then disseminate hematogenously. The primary target organs are the renal tubules and hepatic parenchyma, where the organisms adhere to epithelial cells via outer membrane proteins (OMPs) such as Loa22 [1]. The host immune response involves both humoral and cellular components; opsonizing antibodies are directed against LPS, while the cGAS-STING pathway mediates type I interferon production that reduces renal colonization [2]. This interferon response is critical in limiting chronic shedding, but suboptimal immunity can result in persistent renal carriage.

Zoonotic Risk and One Health Context

Dogs serve as bridging hosts for zoonotic Leptospira transmission. Infected dogs excrete bacteria in urine for weeks to months after infection, creating an environmental contamination risk for humans, especially in households with immunocompromised individuals or children. Meteorological factors such as rainfall, temperature, and flooding events increase the incidence of canine leptospirosis by expanding habitat for reservoir rodents [3]. A scoping review of international evidence confirmed that heavy precipitation and warmer climates are associated with higher seroprevalence in companion animals [3]. In rural Colombia, a One Health study revealed that dog seropositivity correlates with bovine herd infection and proximity to water sources, emphasizing interspecies transmission cycles [4]. Similarly, systematic reviews and meta-analyses of canine leptospirosis in China have identified rural-urban gradients and seasonal peaks linked to rodent density [5]. Indigenous communities, such as the Fulni-ô in Brazil, exhibit high seroprevalence in dogs, reflecting close human-animal-environment interfaces [6]. Genomic comparisons of L. interrogans isolates from humans, dogs, and wild animals in Japan have demonstrated near-identical strain sharing, confirming that canine cases are sentinel events for human risk [7]. The World Organisation for Animal Health (WOAH) recognizes canine leptospirosis as a reportable zoonosis in many regions.

Clinical Manifestations and Biomarkers

Acute leptospirosis in dogs typically presents with fever, lethargy, vomiting, polyuria, polydipsia, and icterus. Renal involvement is characterized by acute kidney injury (AKI) with azotemia, isosthenuria, and tubular necrosis. Hepatic injury manifests as cholestatic enzyme elevation and hyperbilirubinemia. Pulmonary involvement, though less common, can progress to leptospiral pulmonary hemorrhage syndrome (LPHS), which carries a guarded prognosis. A serial evaluation of pulmonary changes in affected dogs documented progressive increases in lung ultrasound scores and alveolar consolidation patterns, with many animals requiring mechanical ventilation [8]. Biomarkers such as serum sialic acid have been investigated as inflammatory markers, with elevated levels correlating with infection and inflammation severity in veterinary patients [9]. Signalment factors, including breed and age, also influence presentation; young, large-breed, outdoor dogs are at highest risk.

Diagnostic Approaches

Definitive diagnosis relies on a combination of serological and molecular methods. The reference standard for serology is the microscopic agglutination test (MAT), which detects antibodies against live Leptospira serogroups. A fourfold rise in paired titers or a single high titer in a clinically compatible case is considered diagnostic. However, MAT has limitations, including the requirement for a panel of live reference serogroups, subjective interpretation, and poor sensitivity early in infection. Molecular diagnostics, particularly quantitative PCR (qPCR) targeting genes such as lipL32 or secY, offer higher sensitivity and specificity during the acute phase. PCR on blood, urine, or tissue can detect leptospiral DNA before seroconversion. Multiplex qPCR panels can simultaneously identify multiple pathogenic species. A lateral flow assay based on recombinant Loa22 conjugated to gold nanoparticles has been developed for serodiagnosis in canine and bovine samples, providing rapid, point-of-care detection without cold chain requirements [1]. In a clinical outbreak investigation in Los Angeles County, PCR testing on urine samples was instrumental in identifying cases that were MAT-negative early in the course [10]. Molecular surveillance studies from Thailand and Colombia have demonstrated that PCR-based species identification reveals a wider diversity of infecting strains than MAT alone, including emerging serogroups such as Australis and Pomona [11, 12]. The diagnostic workflow is summarized in the decision tree below.

flowchart TD
    A[Canine patient with fever, azotemia, icterus], > B{Urine or blood sample}
    B, > C[MAT serology (paired if possible)]
    B, > D[Real-time PCR (lipL32/secY)]
    C, > E{Paired titer rise or single high titer?}
    D, > F{Positive PCR?}
    E, > |Yes| G[Presumptive leptospirosis]
    E, > |No| H[Retest later or consider PCR]
    F, > |Yes| I[Confirmed acute infection]
    F, > |No| J[Consider other causes or seroconversion window]
    G, > K[Initiate antibiotic therapy & supportive care]
    I, > K
    K, > L[Monitor renal/hepatic function]
    L, > M{Culture or MAT for serogroup identification}
    M, > N[Targeted vaccination & zoonotic risk counseling]

Table 1. Comparison of Diagnostic Methods

Serovar Epidemiology and Emerging Serogroups

Historically, canine vaccines have covered serogroups Canicola and Icterohaemorrhagiae. However, global surveillance data indicate increasing prevalence of serogroups Australis, Grippotyphosa, Pomona, and Sejroe in dog populations. An outbreak investigation in Los Angeles County (2021) revealed that the predominant infecting serogroup was Australis, which was not covered by the then-current bivalent vaccines [10]. Similarly, molecular characterization from the Yangtze River region of China found seroprevalence predominantly against serogroups Icterohaemorrhagiae and Javanica, with molecular confirmation of L. interrogans and L. borgpetersenii in urban dogs [13]. The emergence of these serogroups is driven by ecological changes, including encroachment of wildlife reservoirs such as raccoons, opossums, and feral swine into peri-urban environments. A genomic comparison of isolates from Japan underscored the close relationship between human, canine, and wildlife strains, indicating that cross-species transmission is frequent [7]. In neutering campaigns in Thailand, L. interrogans was identified in both dogs and cats, suggesting that cats may also serve as incidental hosts and potential sentinels [11].

Vaccination Strategies

Standard canine leptospirosis vaccines are bacterins containing inactivated whole-cell antigens of selected serogroups. Despite widespread use, vaccine efficacy is serogroup-specific, and protection does not cross-protect against heterologous serogroups. Therefore, a dog vaccinated against Canicola and Icterohaemorrhagiae may still become infected with Australis or Pomona. Recent vaccine formulations include quadrivalent products covering Canicola, Icterohaemorrhagiae, Grippotyphosa, and Pomona. Nevertheless, the antigenic diversity of circulating strains limits universal protection. A systematic review of Chinese epidemiology noted that serogroups not included in commercial vaccines are increasingly detected, highlighting the need for region-specific vaccine updates [5]. The duration of immunity from bacterins is relatively short, typically 12 months, necessitating annual revaccination. Non-core status in vaccination guidelines means many dogs remain unprotected, especially those with outdoor access. Zoetis and other manufacturers have developed recombinant vaccines targeting conserved outer membrane proteins, but these are not yet commercially licensed for dogs. Risk-based vaccination recommendations should consider local serovar prevalence, dog lifestyle, and contact with wildlife.

Table 2. Commonly Included Serogroups in Canine Vaccines and Emerging Serogroups

Treatment and Prognosis

Antibiotic therapy consists of two phases: acute systemic therapy with intravenous penicillin derivatives or doxycycline, followed by a course of doxycycline to eliminate renal carriage. Supportive care includes fluid therapy to manage AKI, antiemetics, and, in cases of severe pulmonary hemorrhage, oxygen supplementation and mechanical ventilation. Prognosis depends on the severity of organ involvement; dogs that survive the first 48 hours often recover, but chronic kidney disease can develop. Serial monitoring of serum creatinine, bilirubin, and lung ultrasound scores provides prognostic insight [8]. The role of serum sialic acid as a prognostic biomarker remains experimental but promising [9]. Antimicrobial resistance in Leptospira has not been extensively documented, but susceptibility testing guidelines exist for doxycycline and penicillin.

Conclusion

Canine leptospirosis remains a significant zoonotic disease with evolving serogroup dynamics driven by environmental change. Accurate diagnosis requires early PCR testing complemented by MAT serology, with emerging rapid lateral flow assays offering field-deployable options. Vaccination must be adapted to local serovar circulation, and veterinarians should counsel clients on zoonotic risk reduction, including rodent control, urine avoidance, and hygiene. Ongoing genomic surveillance and One Health collaborations are essential to track emerging strains and refine prevention strategies.

References

[1] Gautam H, Kumar BVS, Singh S et al. Evaluation of a recombinant Loa22-gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine. Arch Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41524783/

[2] Gupta S, Matsunaga J, Ratitong B et al. cGAS-STING dependent type I IFN reduces Leptospira interrogans renal colonization in mice. PLoS Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41499635/

[3] Hobson SJ, Zai B, Vyn CM et al. Impacts of meteorological factors on zoonotic infections in domestic cat and dog populations: A scoping review of international evidence. One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42211529/

[4] Patiño-Gómez S, Naranjo-Vargas LF, Aguirre-Acevedo DC et al. Epidemiological study of leptospiral interaction in bovine farms in rural areas of Colombia: A One Health approach. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42090421/

[5] Wei W, Jiao D, Dong X et al. Epidemiology and associated factors of human and canine leptospirosis in China: a systematic review and meta-analysis. Prev Vet Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864068/

[6] Galvão CMMQ, Leite DPSBM, Oliveira PRF et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-ô Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41849483/

[7] Kakita T, Takabe K, Morita M et al. Genomic comparison of Leptospira interrogans isolated from humans, dogs, and wild and feral animals in Japan. Int J Med Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41579465/

[8] Bringold C, Schweighauser A, Walther S et al. Serial evaluation of clinical, functional, and structural pulmonary changes in 10 dogs with leptospirosis. J Vet Intern Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42224492/

[9] Yaghoobpour T, Faraji M, Nazifi S. Serum Sialic Acid as a Biomarker of Inflammation and Infection: Insights From Veterinary Medicine. Vet Med Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42148179/

[10] Randolph MW, Nally JE, Yoshimoto SK et al. Clinical and molecular characterization of an outbreak of leptospirosis in dogs from Los Angeles County, California, USA, 2021. J Clin Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42189535/

[11] Thongdee M, Chaiwattanarungruengpaisan S, Paungpin W et al. Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41637464/

[12] Beltrán-Sánchez CA, Bettin AC, Castellanos-Romero K et al. Molecular surveillance of Leptospira infection in domestic dogs in Soledad, Northern Colombia. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41557245/

[13] Ding Y, Zhang S, Zhang W et al. Seroprevalence and Molecular Epidemiology of Leptospira spp. Infecting Dogs in the Yangtze River Region of China. Transbound Emerg Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41383393/

[14] Skinner VJ, Ward MP, Griebsch C. Risk of infection in dogs in contact with clinical canine leptospirosis cases. Aust Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41814781/

[15] Decoster C, Lefère L, Raes E et al. Equine leptospiral pulmonary haemorrhage syndrome: An atypical manifestation of equine leptospirosis. Equine Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41451997/